(Q33845555)

29 July 2017

title

Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival (English)

1 reference

29 July 2017

1 reference

Reza Dana

1 reference

29 July 2017

Sunil K Chauhan

1 reference

29 July 2017

Mohammad H Dastjerdi

1 reference

29 July 2017

Daniel R Saban

1 reference

29 July 2017

Andre Okanobo

1 reference

29 July 2017

Nambi Nallasamy

1 reference

29 July 2017

Zahra Sadrai

1 reference

29 July 2017

Amir R Hajrasouliha

1 reference

29 July 2017

language of work or name

English

0 references

publication date

5 November 2009

1 reference

Investigative Ophthalmology Visual Science

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

2411-2417

1 reference

Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Anti-VEGF therapy: comparison of current and future agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Interaction between bevacizumab and murine VEGF-A: a reassessment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Subconjunctival bevacizumab injection for corneal neovascularization.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

The impact of corneal allograft rejection on the long-term outcome of corneal transplantation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Corneal neovascularization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Angiogenesis in cancer, vascular, rheumatoid and other disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Induction of conjunctival transdifferentiation on vascularized corneas by photothrombotic occlusion of corneal neovascularization

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Topical modulation of interleukin-1 activity in corneal neovascularization

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Promotion of Graft Survival by Vascular Endothelial Growth Factor A Neutralization After High-Risk Corneal Transplantation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

Inhibition of Hemangiogenesis and LymphangiogenesisafterNormal-Risk Corneal Transplantation by Neutralizing VEGF Promotes Graft Survival

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2868492

The effect of topical bevacizumab on corneal neovascularization

29 October 2018

1 reference

12 December 2020

Hierarchy of prognostic factors for corneal allograft survival

1 reference

12 December 2020

Factors Predictive of Corneal Graft Survival

1 reference

12 December 2020

Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply

1 reference

12 December 2020

The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group

1 reference

12 December 2020

Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group

1 reference

12 December 2020

The relative importance of risk factors used to define high-risk keratoplasty

1 reference

12 December 2020

Loss and restoration of immune privilege in eyes with corneal neovascularization

1 reference

12 December 2020

Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits

1 reference

12 December 2020

Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis

1 reference

12 December 2020

Topical bevacizumab therapy for corneal neovascularization

1 reference

12 December 2020

Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome

1 reference

12 December 2020

Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas

1 reference

12 December 2020

Identifiers

DOI

10.1167/IOVS.09-3745

1 reference

29 July 2017

1 reference

29 July 2017

1 reference